Uses beads coated with an antibody that recognizes Protein A, a surface antigen on S. aureus.
71
New cards
Protein A
A surface antigen on Staphylococcus aureus that can be recognized in an agglutination test.
72
New cards
Immunofluorescence
An immunoassay that uses fluorescently labeled antibodies to detect antigens or antibodies.
73
New cards
Direct immunofluorescence
Fixes a specimen to a slide and stains it with antibody-linked fluorophores to detect an antigen in the specimen.
74
New cards
Indirect immunofluorescence
Detects antibodies in a patient's blood serum after exposure to a pathogen.
75
New cards
Indirect immunofluorescence: components
Known antigen, patient serum containing possible antibodies, and a fluorescently labeled secondary antibody.
76
New cards
Positive indirect immunofluorescence
Fluorescence is detected, indicating antibodies in the patient's serum recognize the known antigen.
77
New cards
Negative indirect immunofluorescence
No fluorescence is detected because the patient's serum does not contain the antibody being tested for.
78
New cards
Direct versus indirect immunofluorescence
Direct detects antigen in a specimen using a fluorescently labeled antibody; indirect detects antibodies in patient serum using a known antigen and fluorescent secondary antibody.
79
New cards
ELISA
Enzyme-linked immunosorbent assay; an immunoassay that uses enzyme-linked antibodies.
80
New cards
Direct ELISA
An enzyme-linked antibody binds directly to an antigen.
81
New cards
Indirect ELISA
An enzyme-linked antibody binds to another antibody.
82
New cards
MRSA identification: Gram stain and culture
Look for Gram-positive cocci in clusters and culture the specimen aerobically.
83
New cards
MRSA identification: biochemical tests
Look for catalase-positive and coagulase-positive results consistent with S. aureus.
84
New cards
MRSA identification: Chromeagar
Culture the specimen on Chromeagar containing penicillin; the medium distinguishes S. aureus from close relatives by color.
85
New cards
MRSA identification: qPCR
Amplify the mecA gene, which is associated with methicillin resistance, and the nuc gene, which encodes a nuclease unique to S. aureus.
86
New cards
mecA gene
Associated with methicillin resistance; can be targeted by qPCR when identifying MRSA.
87
New cards
nuc gene
Encodes a nuclease unique to Staphylococcus aureus; can be targeted by qPCR to identify S. aureus.
88
New cards
MRSA identification: agglutination
Look for agglutination when cells are mixed with beads coated in an antibody that recognizes Protein A.
89
New cards
Four approaches to identifying MRSA
Symptoms and clinical presentation, culture and biochemical tests, qPCR for mecA and nuc, and Protein A agglutination.
90
New cards
Next-generation sequencing in clinical diagnostics
A culture-independent method shown for identifying pathogens, including in clinical metagenomic testing.
91
New cards
Biosafety levels (BSL)
Containment levels used when working with pathogens; different levels are required because pathogens differ in risk.
92
New cards
Why different biosafety levels are required
To provide appropriate containment and precautions based on the risk posed by the pathogen.
93
New cards
Highest biosafety level
BSL-4.
94
New cards
BSL-1
Low-risk organisms that are not known to consistently cause disease in healthy adults.
95
New cards
Examples of BSL-1 organisms
Lactobacillus and Vibrio fischeri.
96
New cards
BSL-2
Organisms associated with human disease but not transmitted by aerosols, according to the lecture.
97
New cards
Examples of BSL-2 organisms
Salmonella, E. coli O157:H7, and Staphylococcus aureus.
98
New cards
BSL-3
Organisms with potential for aerosol transmission and serious or lethal consequences.
99
New cards
Examples of BSL-3 organisms
Clostridium botulinum and Mycobacterium tuberculosis.
100
New cards
BSL-4
Life-threatening agents that are unknown or aerosol-transmitted, representing the highest risk level.